Mitochondrial disease
Gene: L2HGDH
DEFINITIVE by ClinGen Mitochondrial GCEP.
More than 100 affected individuals have been reported with a generally consistent phenotype with predominant neurologic involvement (intellectual disability, seizures, developmental delay, ataxia movement disorders, spastic paraplegia, white matter disease, basal ganglia lesions) and elevated L-2-hydroxyglutaric acid in urine and other body fluids.
This gene-disease association is supported by other genes with a similar biochemical function, RNA expression studies showing high expression of L2HGDH in brain, and animal models (mice and canines) which parallel human disease.Created: 5 Dec 2025, 12:01 p.m. | Last Modified: 5 Dec 2025, 12:01 p.m.
Panel Version: 0.1116
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
L-2-hydroxyglutaric aciduria, MIM#236792
Publications
Gene: l2hgdh has been classified as Green List (High Evidence).
Phenotypes for gene: L2HGDH were changed from Disorders of mitochondrial metabolite repair; L-2-hydroxyglutaric aciduria MONDO:0009370 to L-2-hydroxyglutaric aciduria, MIM#236792
Publications for gene: L2HGDH were set to 29884839; 37995940
gene: L2HGDH was added gene: L2HGDH was added to Mitochondrial disease. Sources: Expert Review Green Mode of inheritance for gene: L2HGDH was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: L2HGDH were set to 29884839; 37995940 Phenotypes for gene: L2HGDH were set to Disorders of mitochondrial metabolite repair; L-2-hydroxyglutaric aciduria MONDO:0009370